Murphy, D. A., Makonnen, S., Lassoued, W., Feldman, M. D., Carter, C., & Lee, W. M. (2006). Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth by Sorafenib (BAY43-9006). American Society for Investigative Pathology.
Citação norma ChicagoMurphy, Danielle A., Sosina Makonnen, Wiem Lassoued, Michael D. Feldman, Christopher Carter, and William M.F Lee. Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth By Sorafenib (BAY43-9006). American Society for Investigative Pathology, 2006.
Citação norma MLAMurphy, Danielle A., et al. Inhibition of Tumor Endothelial ERK Activation, Angiogenesis, and Tumor Growth By Sorafenib (BAY43-9006). American Society for Investigative Pathology, 2006.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.